Investigation of Maternal Effects, Maternal-Fetal Interactions, and Parent-of-Origin Effects (Imprinting) for Candidate Genes Positioned on Chromosome 18q21, in Probands with Schizophrenia and their First-Degree Relatives

키워드

참고문헌 (81)

1. McGuffin P, "The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia?", Br J Psychiatry, 164, pp.593~599 (1994)
2. Bachmann RF, "Mood stabilizers target cellular plasticity and resilience cascades : implications for the development of novel therapeutics", Mol Neurobiol, 32, pp.173~202 (2005)
3. Bartels SJ, "Medicare and medicaid costs for schizophrenia patients byage cohort compared with costs for depression, dementia, and medically ill patients", Am J Geriatr Psychiatry, 11, pp.648~657 (2003)
4. Bauer M, "NIMH Affective Disorders Workgroup Bipolar disorder", Ment Health Serv Res, 4, pp.225~229 (2002)
5. Shih RA, "A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders", Int Rev Psychiatry, 16, pp.260~283 (2004)
6. Van Broeckhoven, "Report of the chromosome 18 workshop", Am J Med Genet, 88, pp.263~270 (1999)
7. Pulver AE, "Genetic heterogeneity in schizophrenia : stratification of genome scan data using co-segregating related phenotypes", Mol Psychiatry, 5, pp.650~653 (2000)
8. Siris SG, "Depression in schizophrenia : perspective in the era of"Atypical"antipsychotic agents", Am J Psychiatry, 157, pp.1379~1389 (2000)
9. Bailer U, "Genome scan for susceptibility loci for schizophrenia and bipolar disorder", Biol Psychiatry, 52, pp.40~52 (2002)
10. Cardno AG, "A twin study of genetic relationships between psychotic symptoms", Am J Psychiatry, 159, pp.539~545 (2002)
11. Potash JB, "Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder", Am J Psychiatry, 160, pp.680~686 (2003)
12. Walss-Bass C, "Evidence of genetic overlap of schizophrenia and bipolar disorder : linkage disequilibrium analysis of chromosome 18 in the Costa Rican population", Am J Med Genet, 139, pp.54~60 (2005)
13. Escamilla MA, "Population isolates : their special value for locating genes for bipolar disorder", Bipolar Disord, 3, pp.299~317 (2001)
14. Williams NM, "A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs", Hum Mol Genet, 8, pp.1729~1739 (1999)
15. Ewald H, "Susceptibility loci for bipolar affective disorder on chromosome 18? A review and a study of Danish families", Psychiatr Genet, 7, pp.1~12 (1997)
16. Maziade M, "A search for specific and common susceptibility loci for schizophrenia and bipolar disorder : a linkage study in 13 target chromosomes", Mol Psychiatry, 6, pp.684~693 (2001)
17. Buyske S, "Maternal genotype effects can alias case genotype effects in case-control studies", Eur J Hum Genet, 16, pp.784~785 (2008)
18. Goddard KA, "Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes", Hum Hered, 63, pp.1~16 (2007)
19. Schneider K, "HLA antigen sharing in preeclampsia", Gynecol Obstet Invest, 37, pp.87~90 (1997)
20. Wilson ML, "Molecular epidemiology of preeclampsia", Obstet Gynecol Surv, 58, pp.39~66 (2003)
21. Larizza D, "Parental GM and HLA genotypes and reduced birth weight in patients with Turner’s syndrome", J Pediatr Endocrinol Metab, 15, pp.1183~1190 (2005)
22. Ober C, "Prenatal effects of maternal-fetal HLA compatibility", Am J Reprod Immunol Microbiol, 15, pp.141~149 (1987)
23. Jensen LE, "Maternal genotype for the monocyte chemoattractant protein 1 A(-2518)G promotor polymorphism is associated with the risk of spina bifida in offspring", Am J Med Genet A, 140, pp.1114~1118 (2006)
24. Palmer CG, "HLA-B maternal-fetal genotype matching increases risk of schizophrenia", Am J Hum Genet, 79, pp.710~715 (2006)
25. Cordell HJ, "Case", pseudocontrol analysis in genetic association studies : a unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions and parent-of-origin effects, 2004, pp.26, 167~185
26. Hsieh HJ, "The v-MFG test : investigating maternal, offspring and maternal-fetal genetic incompatibility effects of disease and viability", Genet Epidemiol, 30, pp.333~347 (2006)
27. Shi M, "Making the most of case-mother", control-mother studies, 2008, pp.168, 541~547
28. Sinsheimer JS, "Detecting genotype combinations that increase risk for disease : maternal-fetal genotype incompatibility test", Genet Epidemiol, 24, pp.1~13 (2003)
29. Weinberg CR, "Methods for detection of parent-of-origin effects in genetic studies of case-parents triads", Am J Hum Genet, 65, pp.229~235 (1999)
30. Weinberg CR, "A log-linear approach to caseparent triad data : assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting", Am J Hum Genet, 62, pp.969~978 (1998)
31. Weinberg CR, "The genetics of preterm birth : using what we know to design better association studies", Am J Epidemiol, 170, pp.1373~1381 (2009)
32. Jamieson SE, "Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis", PLoS One, 3, pp.e2285~ (2008)
33. Chen J, "Likelihood ratio tests for maternal and fetal genetic effects on obstetric complications", Genet Epidemiol, 33, pp.526~538 (2009)
34. Li S, "A regularized regression approach for dissecting genetic conflicts that increase disease risk in pregnancy", Stat Appl Genet Mol Biol, 8, pp.45~ (2009)
35. Weinberg CR, "A hybrid design for studying genetic influences on risk of diseases with onset early in life", Am J Hum Genet, 77, pp.627~636 (2005)
36. Spielman RS, "Transmission test for linkage disequilibrium : The insulin gene region and insulin?dependent diabetes mellitus", Am J Hum Genet, 52, pp.506~516 (1993)
37. WTCCC, "Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls", Nature, 447, pp.661~678 (2007)
38. Devlin B, "Genomic control for association studies", Biometrics, 55, pp.997~1004 (1999)
39. Price AL, "Principal components analysis corrects for stratification in genomewide association studies", Nat Genet, 38, pp.904~909 (2006)
40. Pritchard JK, "Association mapping in structured populations", Am J Hum Genet, 67, pp.170~181 (2000)
41. Cordell HJ, "A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case", control or family data : application to HLA in type 1 diabetes, 2002, pp.70, 124~141
42. Schaid DJ, "General score tests for associations of genetic markers with disease using cases and their parents", Genet Epidemiol, 13, pp.423~449 (1996)
43. Schaid DJ, "Genotype relative risks : methods for design and analysis of candidate-gene association studies", Am J Hum Genet, 53, pp.1114~1126 (1993)
44. Shi M, "Using case-parent triads to estimate relative risks associated with a candidate haplotype", Ann Hum Genet, 73, pp.346~359 (2009)
45. Vermeulen SH, "A hybrid design : case-parent triads supplemented by control-mother dyads", Genet Epidemiol, 33, pp.136~144 (2009)
46. Escamilla MA, "Use of linkage disequilibrium approaches to map genes for bipolar disorder in the Costa Rican population", Am J Med Genet, 67, pp.244~253 (1996)
47. Mathews CA, "Genetic studies of neuropsychiatric disorders in Costa Rica : a model for the use of isolated populations", Psychiatr Genet, 14, pp.13~23 (2004)
48. Escamilla MA, "Assessing the feasibility of linkage disequilibrium methods for mapping complex traits : an initial screen for bipolar disorder loci on chromosome 18", Am J Hum Genet, 64, pp.1670~1678 (1999)
49. Nurnberger JI Jr, "NIMH Genetics Initiative", Arch Gen Psychiatr, 51, pp.849~859 (1994)
50. Joo EJ, "Korean version of the diagnostic interview for genetic studies : Validity and reliability", Compr Psychiatry, 45, pp.225~229 (2004)
51. Maxwell ME, "Family Interview for Genetic Studies (FIGS): Manual for FIGS. Clinical Neurogenetics Branch, Intramural Research Program", National Institute of Mental Health, ~ (1992)
52. Laird NM, "Implementing a unified approach to family-based tests of association", Genet Epidemiol, 19(Suppl 1), pp.S36~S42 (2000)
53. Barrett JC, "Haploview : analysis and visualization of LD and haplotype maps", Bioinformatics, 21, pp.263~265 (2005)
54. Ainsworth HF, "Investigation of maternal effects, maternal-foetal interactions and parent-of-origin effects(imprinting), using mothers and their offspring", Genet Epidemiol, 35, pp.19~45 (2011)
55. Ohki I, "Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA", Cell, 105, pp.487~497 (2001)
56. Carney RM, "Identification of MeCP2 mutations in a series of females with autistic disorder", Pediatr Neurol, 28, pp.205~211 (2003)
57. Greenberg DA, "Malic enzyme 2 may underlie susceptibility to adolescentonset idiopathic generalized epilepsy", Am J Hum Genet, 76, pp.139~146 (2005)
58. Itoh S, "Signaling of transforming growth factor-β family members through Smad proteins", Eur J Biochem, 267, pp.6954~6967 (2000)
59. Lu J, "SMAD pathway mediation of BDNF and TGFβ2 regulation of proliferation and differentiation of hippocampal granule neurons", Development, 132, pp.3231~3242 (2005)
60. Cho MJ, "Pilot study for family-based association analysis of schizophrenia in a Korean population : Analysis for candidate genes positionally on chromosome 18q21", Asia Pac Psychiatry, 7, pp.268~275 (2015)
61. Lee BD, "Malic enzyme 2 and susceptibility to psychosis and mania", Psychiatry Res, 150, pp.1~11 (2007)
62. Resh MD, "Trafficking and signaling by fatty-acylated and prenylated proteins", Nat Chem Biol, 2, pp.584~590 (2006)
63. Greaves J, "Palmitoylation-dependent protein sorting", J Cell Biol, 176, pp.249~254 (2007)
64. Salaun C, "The intracellular dynamic of protein palmitoylation", J Cell Biol, 191, pp.1229~1238 (2010)
65. Linder ME, "Palmitoylation : policing protein stability and traffic", Nat Rev Mol Cell Biol, 8, pp.74~84 (2007)
66. Fukata Y, "Protein palmitoylation in neuronal development and synaptic plasticity", Nat Rev Neurosci, 11, pp.161~175 (2010)
67. Schlesinger MJ, "Fatty acid acylation of proteins in cultured cells", J Biol Chem, 255, pp.10021~10024 (1980)
68. Fukata M, "Identification of PSD-95 palmitoylating enzymes", Neuron, 44, pp.987~996 (2004)
69. Greaves J, "DHHC palmitoyl transferases : substrate interactions and(patho)physiology", Trends Biochem Sci, 36, pp.245~253 (2011)
70. Jennings BC, "DHHC Protein S-Acyltransferases use a similar ping-pong kinetic mechanism but display different acyl-CoA specificities", J Biol Chem, 287, pp.7236~7245 (2012)
71. Young FB, "Putting proteins in their place : palmitoylation in Huntington disease and other neuropsychiatric diseases", Prog Neurobiol, 97, pp.220~238 (2012)
72. Yamamoto Y, "33 is associated with progression of bladder cancer", Oncology, 72, pp.132~138 (2007)
73. Kang JU, "Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer", Cancer Genet Cytogenet, 182, pp.1~11 (2008)
74. Yan SM, "Reduced expression of ZDHHC2 is associated with lymph node metastasis and poor prognosis in gastric adenocarcinoma", PLoS One, 8, pp.e56366~ (2013)
75. Oyama T, "Isolation of a novel gene on 8p21.3?22 whose expression is reduced significantly in human colorectal cancers with liver metastasis", Genes Chromosomes Cancer, 29, pp.9~15 (2000)
76. Birkenkamp-Demtroder K, "Gene expression in colorectal cancer", Cancer Res, 62, pp.4352~4363 (2002)
77. Basso AD, "Thematic review series: lipid posttranslational modifications. Farnesyl transferase inhibitors", J Lipid Res, 47, pp.15~31 (2006)
78. Yeste-Velasco M, "Identification of ZDHHC14 as a novel human tumour suppressor gene", J Pathol, 232, pp.566~577 (2014)
79. Greaves J, "New links between S-acylation and cancer", J Pathol, 233, pp.4~6 (2014)
80. Allen KM, "Gonadectomy increases neurogenesis in the male adolescent rhesus macaque hippocampus", Hippocampus, 24, pp.225~238 (2014)
81. Mortensen PB, "The occurrence of cancer in first admitted schizophrenic patients", Schizophr Res, 12, pp.185~194 (1994)

관련 논문AI추천